We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

arGEN-X Enters Long-term Strategic Alliance with Shire in Therapeutic Antibodies

News   Jun 05, 2014

 
arGEN-X Enters Long-term Strategic Alliance with Shire in Therapeutic Antibodies
 
 
Advertisement
 

RELATED ARTICLES

mRNA Delivery System Produces Therapeutic Protein in Rat Brains

News

Researchers from Tokyo Medical and Dental University (TMDU) demonstrate an mRNA delivery system that effectively produces BDNF protein in rat brain to protect neurons from ischemia.

READ MORE

Reviving Failed Antibody Treatments for Solid Tumors

News

Lab-engineered antibodies remain the core facilitator of immunotherapies and CAR T-cell therapies. But these therapies have proved less effective against solid tumors, compared with other cancers. Now, researchers have uncovered why some of these antibody approaches appear to effectively kill cancer tumors in laboratory tests but are ineffective in clinical trials.

READ MORE

Elusive Inner Workings of Antioxidant Enzyme Revealed

News

Researchers from the University of Nebraska Medical Center (UNMC) and the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL) have now observed the complete atomic structure of an enzyme called manganese superoxide dismutaseMnSOD, including its proton arrangements, with neutron scattering.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE